Suppr超能文献

将阿育吠陀概念转化为现代药物结构:一种新范式。

Translating Ayurvedic concepts to modern drug structures: A novel paradigm.

作者信息

Morandi Antonio, Minniti Maria Cristina, Nambi An Narayanan

机构信息

Ayurvedic Point, Corso Sempione 63, 20149, Milan, Italy.

Ayurvedic Point, Corso Sempione 63, 20149, Milan, Italy.

出版信息

J Ayurveda Integr Med. 2025 Aug 1;16(5):101203. doi: 10.1016/j.jaim.2025.101203.

Abstract

Modern pharmacology faces challenges in fully explaining inter-individual variability in drug efficacy and side effects. This article introduces a groundbreaking approach that applies Ayurvedic principles to interpret modern drug structures and actions, offering a more comprehensive framework for understanding drug behavior. Through the Collaborative Medicine and Science (Co.M.S.) framework, we demonstrate how Ayurvedic epistemology provides a holistic reading of modern pharmaceuticals using fundamental principles of Panchamahabhuta, Tridosha, and Guna. This Ayurvedic interpretation reveals how drug effects (Karma) emerge from the interaction between a substance's inherent qualities (Guna profile) and an individual's constitutional context (Prakriti/Vikriti), explaining inter-individual variability in drug responses. Illustrative examples using antibiotics and antihypertensives demonstrate how this approach can optimize prescription practices, reduce side effects, and lower healthcare costs. While empirical validation will strengthen this approach, it already offers valuable practical insights that complement-not replace-conventional pharmacology, potentially enhancing personalized medicine and patient outcomes.

摘要

现代药理学在充分解释药物疗效和副作用的个体差异方面面临挑战。本文介绍了一种开创性的方法,该方法应用阿育吠陀原则来解释现代药物的结构和作用,为理解药物行为提供了一个更全面的框架。通过协作医学与科学(Co.M.S.)框架,我们展示了阿育吠陀认识论如何运用五大元素、三体液和属性的基本原理对现代药物进行整体解读。这种阿育吠陀解读揭示了药物作用( Karma )是如何从物质的固有特性(属性概况)与个体体质背景(原质/变异质)之间的相互作用中产生的,解释了药物反应的个体差异。使用抗生素和抗高血压药物的示例说明了这种方法如何优化处方实践、减少副作用并降低医疗成本。虽然实证验证将加强这种方法,但它已经提供了有价值的实践见解,这些见解是对传统药理学的补充而非替代,有可能增强个性化医疗和改善患者预后。

相似文献

6
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.

本文引用的文献

3
The integration quagmire: Why we need to watch our steps.整合困境:为何我们需谨慎行事。
Anc Sci Life. 2015 Jan-Mar;34(3):123-5. doi: 10.4103/0257-7941.157144.
7
Systems approaches to biology and disease enable translational systems medicine.系统生物学和疾病的系统方法能够实现转化系统医学。
Genomics Proteomics Bioinformatics. 2012 Aug;10(4):181-5. doi: 10.1016/j.gpb.2012.08.004. Epub 2012 Aug 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验